SIGN UP

top stories

Vertex, Alpine’s IgAN drug has Humira-like potential. But not all indications are created equal

15 hours ago

Rare neuro disorder offers new area for competition, analysts say: #AAN24

17 hours ago

J&J's AI head jumps to Recursion; Doug Williams resigns as Sana's R&D chief

17 hours ago

Latest

Takeda wins label expansion for subcutaneous Entyvio, creating 'flexibility' for Crohn's patients

10 hours ago

CSL Vifor proposes a marketing campaign to settle European Commission investigation

10 hours ago

Senators want to know more on why Novo is discontinuing its insulin Levemir

11 hours ago

Califf talks bolstering domestic drug manufacturing, foreign inspections at House hearing

11 hours ago

see latest stream

People

Exclusive: Ancestry cut 6% of workforce as genealogy giant struggles with subscription revenue

2 days ago

Canaan adds $100M+ to boost biopharma investing, brings on former Pfizer exec

2 days ago

Fujifilm may cut 240 workers and rebuild early-stage biologics, CGT unit

2 days ago

Financing

Corner Therapeutics to hyperactivate ‘the brains of the immune system’ with $54M launch

Yesterday

Bristol Myers pitches in to Pathios’ $25M Series B for GPCR inhibitor

Yesterday

ARCH-backed startup Metsera launches with $290M to take on obesity giants

Yesterday

Startups

Obesity drugmaker lands first biopharma uplisting onto Nasdaq since last summer

Last week

Exclusive: Siduma, a biotech from Arvinas' scientific founder, shutters due to 'financing environment'

Last week

Another ADC biotech reels in big bucks as Mark Alles’ TORL nabs $158M

Last week

Deals

Bruker to acquire troubled spatial biology company NanoString for $392M

Yesterday

Sanofi's trimmed oncology plans lead to $3B biobucks dent for IGM

2 days ago

AbbVie inks deal for Medincell's long-acting injectable platform worth up to $1.9B

3 days ago

All of the news, delivered with full-text to your inbox. For professionals discovering, developing, and marketing biopharmaceutical drugs.

SIGN UP NOW

Subscribe to Endpoints News

In FocusSee all

Cash, chips and talent: Inside Nvidia's plan to dominate biotech's AI revolution

4 days ago

With GIP, obesity research is at odds

4 weeks ago

The US could upend biopharma manufacturing. WuXi rivals have an opening

4 weeks ago

Female investors track progress, call for more women on boards and in leadership roles

Last month

Endpoints Standouts

Cash, chips and talent: Inside Nvidia's plan to dominate biotech's AI revolution

4 days ago

The US could upend biopharma manufacturing. WuXi rivals have an opening

4 weeks ago

Startups raised millions to in-license drugs to China. Then the model fell apart

Last month

The R&D 15: Top pharma players shell out record $153B for research, and M&A is a prime focus for all

Last month

Peer review See all

Apr

12

Illumina CFO to depart; Jude Samulski ends his run as AskBio’s CSO

Apr

5

Acadia snags Amgen, Horizon vet to direct R&D; Samantha Truex steps down as Upstream Bio CEO

Mar

28

Exclusive: ADC startup Mythic recruits Jazz exec to lead company; Dyne’s CEO shuffle

Mar

22

Parexel CEO to retire; CAR-T maker AffyImmune promotes business leader to chief executive

Mar

15

Biogen loses CMO, neuromuscular leader; John Hood adds president, CFO at Endeavor BioMedicines

Pharma channel feed

17 hours ago

Roche's Genentech touts label expansion for blockbuster lung cancer drug Alecensa

Roche’s Genentech said that Alecensa scored a label expansion from the FDA, with the drug now approved as an adjuvant treatment following tumor resection in patients with ...

READ MORE

Lumicell nabs FDA approval for drug-device breast cancer detection system

Yesterday

GSK unveils long-term Shingrix data as shingles competition heats up

2 days ago

latest in Pharma

Lilly, insulin users end $13.5M settlement plan following federal judge's decision

2 days ago

A majority of pharma and biotech companies prohibit ChatGPT use, survey finds

2 days ago

FDA hits Natco with warning letter over India facility, suspends product shipments to US

3 days ago

Sandoz's Humira biosimilar nabs significant market share thanks to CVS partnership

3 days ago

J&J’s multiple myeloma therapies drive oncology business despite slow Carvykti sales

3 days ago

see latest stories

Marketing channel feed

Yesterday

Consumer trust in physicians and pharma is up, but lower for employers and biotech

Trust in the pharma industry is up among consumers, but slipped for the biotech sector in an unusual flip of sentiment about the two industries, according to Edelman’s annual Trust Barometer research.

READ MORE

Sanofi restructures US commercial vaccines sales force

Yesterday

Regeneron and Genentech battle for ophthalmologists’ affinity in Eylea HD, Vabysmo matchup

3 days ago

latest in Marketing

How drugmakers are handling new pressure to recycle plastic injection pens as millions of new patients begin using GLP-1s

3 days ago

MarketingRx roundup: Viatris taps former Moderna exec for commercial chief; Merck debuts PAH effort

3 days ago

Gabrielle Union-Wade promotes self-advocacy at media agency health event

4 days ago

Lights, camera and community: AstraZeneca’s Alexion creates an original film to spotlight rare neurological disorder

Last week

Pharma, health and wellness judges named for 2024 Cannes Lions creative awards

Last week

see latest stories

FDA+ channel feed

3 days ago

Senate bill targeting WuXi won't affect federal spending, CBO says

A Senate bill that would blacklist Chinese biotech companies like WuXi AppTec from doing business in the US may not see a vote until after the election, if ever. But if it does, the ...

READ MORE

GAO examines state PBM regulation as Congress weighs wider reforms

4 days ago

New FDA trial innovation center launches with demonstration to increase industry interactions

4 days ago

latest in FDA+

FDA is ready to eliminate the interchangeability designation for biosimilars

4 days ago

Adcomm backs use of minimal residual disease in multiple myeloma accelerated approvals

Last week

EMA probe finds no causal link between semaglutide and suicidal thoughts, self-harm

Last week

FDA commissioner calls on House committee to help combat drug shortages

Last week

AstraZeneca's Fasenra expands approval in children with severe asthma

Last week

see latest stories

Manufacturing channel feed

Yesterday

Vedanta lays off CMC staffers; Kincell buys Imugene facility for $6M

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.

READ MORE

J&J, Bristol Myers race to amplify CAR-T manufacturing to meet label expansion in multiple myeloma

Yesterday

Fujifilm is all in on ADCs, to sell ‘trust’ to boost manufacturing revenues

2 days ago

latest in Manufacturing

Recipharm’s new CEO on ‘fast and furious’ changes, with eyes on GLP-1, biologics manufacturing

Last week

Fujifilm invests $1.2B to expand North Carolina biomanufacturing facility

Last week

Ascend takes Beacon’s manufacturing assets; 89bio’s $135M build in China

Last week

Moderna halts African facility build as Covid-19 vaccine demand plummets

Last week

US reaches new record of 320+ drugs in active shortage, group says

Last week

see latest stories